BiotechTube

Naloxegol + Naloxegol

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Opioid Induced Constipation

Conditions

Opioid Induced Constipation

Trial Timeline

Jul 1, 2012 → Sep 1, 2012

NCT ID
NCT01623609

About Naloxegol + Naloxegol

Naloxegol + Naloxegol is a phase 1 stage product being developed by AstraZeneca for Opioid Induced Constipation. The current trial status is completed. This product is registered under clinical trial identifier NCT01623609. Target conditions include Opioid Induced Constipation.

What happened to similar drugs?

8 of 20 similar drugs in Opioid Induced Constipation were approved

Approved (8) Terminated (6) Active (7)
✅Naldemedine + PlaceboShionogiApproved
✅Polyethylene Glycol 3350 + MovantikAstraZenecaApproved
✅Naltrexone for extended-release injectable suspension + Oral naltrexoneAlkermesApproved
✅NaltrexoneAlkermesApproved
✅VIVITROL 380mgAlkermesApproved
✅methylnaltrexone + placeboBausch HealthApproved
✅Methylnaltrexone bromideBausch HealthApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01623609Phase 1Completed

Competing Products

20 competing products in Opioid Induced Constipation

See all competitors
ProductCompanyStageHype Score
SUBLOCADEIndivior PLCPhase 3
29
SUBLOCADEIndivior PLCPhase 3
29
ASP8082 + morphine + PlaceboAstellas PharmaPhase 1
29
ASP8062 + Placebo ASP8062 + buprenorphine/naloxoneAstellas PharmaPhase 1
29
ASP8062 + Placebo ASP8062 + buprenorphine/naloxoneAstellas PharmaPhase 2
27
Naldemedine + PlaceboShionogiPhase 3
40
Naldemedine + PlaceboShionogiApproved
50
NaldemedineShionogiPhase 1/2
39
Naldemedine + PlaceboShionogiPhase 3
40
Placebo + NaldemedineShionogiPhase 2
35
Naldemedine + PlaceboShionogiPhase 3
40
Naldemedine + PlaceboShionogiPhase 2
35
NaloxegolKyowa KirinPre-clinical
26
naloxegol + non-PAMORA laxativeKyowa KirinPre-clinical
18
NaloxegolKyowa KirinPre-clinical
26
NaloxegolKyowa KirinPre-clinical
26
Brenipatide + Placebo + BuprenorphineEli LillyPhase 2
42
NKTR-118 + NKTR-118 + PlaceboAstraZenecaPhase 3
32
NKTR-118 + Usual careAstraZenecaPhase 3
40
Polyethylene Glycol 3350 + MovantikAstraZenecaApproved
43